Fair question.
Full text of article is available:
https://www.researchgate.net/figure/Models-of-payment-for-the-participation-of-research-subjects_tbl1_7737793
I searched my journal databases and there are just as many articles stating there are numerous disadvantages associated with payment of subjects. Payment is not common practice in Australia; more common in the US. Regardless, payment in Imagion's trial would require a fairly significant trial re-design...
Should we petition Red Cross to enable payment for plasma donations, and the sprog clinics to pay sperm donors also?
- Forums
- ASX - By Stock
- IBX
- Financial incentives for recruiting is not uncommon
Financial incentives for recruiting is not uncommon
-
-
-
Share
I think it's going to be really hard to get a 15 patient cohort without a trial redesign.
And then what about the next step, 300 people? You can understand the markets apprehension.
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.001(2.17%) |
Mkt cap ! $2.022M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 4.6¢ | $2.887K | 62.23K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6382 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6382 | 0.047 |
2 | 278491 | 0.046 |
1 | 20000 | 0.045 |
2 | 185000 | 0.044 |
1 | 15000 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 20000 | 1 |
0.056 | 13574 | 1 |
0.060 | 10000 | 1 |
0.063 | 38873 | 1 |
0.070 | 822 | 2 |
Last trade - 12.48pm 08/11/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online